Shin Kan
Impact in
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Immunology 19
- Immunotherapy and Immune Responses 11
- Immune Response and Inflammation 7
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 2
- Oncology 12
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 3
- Co-authors
- Masato Okamoto (22 shared papers)Shigeo Koido (22 shared papers)Sadamu Homma (16 shared papers)Masaki Ito (8 shared papers)Akimichi Ohsaka (2 shared papers)Marito Araki (2 shared papers)Yumi Hironaka (2 shared papers)Norio Komatsu (2 shared papers)
- Journals
- OncoImmunology (3 papers)Journal of Immunotherapy (3 papers)BMC Cancer (2 papers)International Journal of Oncology (2 papers)Neoplasia (2 papers)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Shin Kan
35 papers receiving 841 citations
Peers
Comparison fields: 5 of 78
- Genetics 199
- Immunology 334
- Hematology 152
- Oncology 325
- Molecular Biology 250
Countries citing papers authored by Shin Kan
This map shows the geographic impact of Shin Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin Kan more than expected).
Fields of papers citing papers by Shin Kan
This network shows the impact of papers produced by Shin Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin Kan. The network helps show where Shin Kan may publish in the future.
Co-authors
The 25 scholars most cited alongside Shin Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 200 | |
| 2 | 2005 | 56 | |
| 3 | Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity. | 2011 | 53 |
| 4 | Suppressive effects of cyclophosphamide and gemcitabine on regulatory T-cell induction in vitro. | 2012 | 52 |
| 5 | Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy. | 2014 | 43 |
| 6 | 2015 | 43 | |
| 7 | 2013 | 40 | |
| 8 | 2004 | 30 | |
| 9 | 2021 | 27 | |
| 10 | Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer. | 2015 | 27 |
| 11 | 2015 | 26 | |
| 12 | 2015 | 24 | |
| 13 | 2016 | 23 | |
| 14 | 2006 | 21 | |
| 15 | 2017 | 20 | |
| 16 | 2013 | 18 | |
| 17 | 2013 | 17 | |
| 18 | 2003 | 16 | |
| 19 | 2001 | 14 | |
| 20 | 2012 | 14 |
About Shin Kan
Shin Kan is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Genetics, having authored 35 papers that have together received 851 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Immune Response and Inflammation (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (5 papers), RNA Interference and Gene Delivery (3 papers), CAR-T cell therapy research (3 papers), T-cell and B-cell Immunology (2 papers) and Gut microbiota and health (2 papers). The work is most often cited by research in Genetics (199 citations), Immunology (334 citations), Hematology (152 citations), Oncology (325 citations) and Molecular Biology (250 citations). Shin Kan has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Masato Okamoto, Shigeo Koido, Sadamu Homma, Masaki Ito, Akimichi Ohsaka, Marito Araki, Yumi Hironaka, Norio Komatsu, Yoshitaka Sunami and Soji Morishita. Their work appears in journals such as OncoImmunology, Journal of Immunotherapy, BMC Cancer, International Journal of Oncology and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.